General Information of the Compound
Compound ID
CP0564591
Compound Name
4-[3-(5-methylpyrazol-1-yl)propoxy]-6-piperidin-1-ylpyrimidine
    Show/Hide
Structure
Formula
C16H23N5O
Molecular Weight
301.394
Canonical SMILES
Cc1ccnn1CCCOc1cc(ncn1)N1CCCCC1
    Show/Hide
InChI
InChI=1S/C16H23N5O/c1-14-6-7-19-21(14)10-5-11-22-16-12-15(17-13-18-16)20-8-3-2-4-9-20/h6-7,12-13H,2-5,8-11H2,1H3
    Show/Hide
InChIKey
QGAYBIYUOIWNKA-UHFFFAOYSA-N
Physicochemical Property
logP
2.44092
Rotatable Bonds
6
Heavy Atom Count
22
Polar Areas
56.07
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166635102
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05231, Very long chain fatty acid elongase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS